Nutritional Deficiencies Before and After Bariatric Surgery: Prevention and Treatment

Argyrakopoulou, Georgia; Konstantinidou, Sofia K.; Dalamaga, Μaria; Kokkinos, Alexander

doi:10.1007/s13668-022-00400-9

Cited by 27 publications

(38 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Insufficient intake of vitamins and minerals with the diet results in their deficiencies in the body which, if not compensated for, will deepen. As a consequence, many complications may develop, including polyneuropathy, metabolic bone disease, anemia, and Wernicki–Kosrakov disease [ 45 , 46 ].…”

Section: Discussionmentioning

confidence: 99%

Assessment of the Clinical Condition and Way of Patients’ Nutrition before and after Laparoscopic Sleeve Gastrectomy

Jastrzębska-Mierzyńska

Ostrowska

Witczak-Sawczuk

et al. 2023

Nutrients

View full text Add to dashboard Cite

One of the most commonly performed bariatric procedures is the laparoscopic sleeve gastrectomy (LSG). It is highly effective in reducing body weight, but it carries the risk of developing nutritional deficiencies and their consequences. The aim of the study was to determine the clinical condition of obese patients after LSG in terms of nutritional status, metabolic disorders, and way of nutrition. Thirty participants (15 women and 15 men) took part in the study. A statistically significant reduction in the total body fat mass (women by 37.5% p < 0.05, men by 37.06% p < 0.05) and total fat free mass (women by 10% p < 0,05, men by 12.5% p < 0.05) was demonstrated 6 months after LSG. Moreover, insufficient protein intake has been shown in over 73% of women and 40% of men. Before and 6 months after LSG, insufficient intake of calcium, magnesium, potassium, folate, vitamin D, and iron was observed. Six months after the LSG, significant decreases of fasting glucose (p < 0.05), insulin (p < 0.05), TG (p < 0.05), and AST (p < 0.05) concentrations, were observed in both groups. Optimization of nutrition in order to prevent nutritional deficiencies and their complications is a key element of the therapy of obese patients treated surgically.

show abstract

Section: Discussionmentioning

confidence: 99%

Assessment of the Clinical Condition and Way of Patients’ Nutrition before and after Laparoscopic Sleeve Gastrectomy

Jastrzębska-Mierzyńska

Ostrowska

Witczak-Sawczuk

et al. 2023

Nutrients

View full text Add to dashboard Cite

show abstract

“…These deficiencies are often multifactorial. On the one hand, the general intake of vitamins and minerals is altered by the low nutritional quality dietary patterns, rich in energy-dense foods but poor in fruits and vegetables, one of the main sources of vitamins and minerals [22,30]. On the other hand, some deficiencies are due to conditions that occur specifically in PLWO.…”

Section: Pre-operative Nutritional Deficienciesmentioning

confidence: 99%

“…Moreover, there are other factors involved such as an unbalanced diet and lower sun exposure [31]. The absorption of iron may be decreased by the higher levels of hepcidin due to the subclinical inflammatory environment [30]. The identification of nutritional deficiencies prior to surgery and their treatment is essential not only for the patient to present an optimal nutritional status at the time of surgery but also to prevent the development of post-surgical deficiencies and their outcomes.…”

Section: Pre-operative Nutritional Deficienciesmentioning

confidence: 99%

Precision nutrition in the context of bariatric surgery

Aguas-Ayesa

Yárnoz-Esquíroz

Olazarán

et al. 2023

Rev Endocr Metab Disord

View full text Add to dashboard Cite

Bariatric surgery (BS) is the most effective long-term treatment for severe obesity. This review summarizes the main nutritional deficiencies before and after BS, as well as current dietary and supplementation recommendations to avoid them. Likewise, we have reviewed all those aspects that in recent years have been shown to be related to postoperative weight loss (WL) and its subsequent maintenance, such as hormonal changes, dietary patterns, changes in food preference, adherence to recommendations and follow-up, genetic factors and microbiota, among others. Despite all the knowledge, nutritional deficiencies and weight regain after BS are frequent. It is essential to continue studying in this field in order to establish more precise recommendations according to the individual characteristics of patients. It is also a major objective to understand more deeply the role of the factors involved in WL and its maintenance. This will allow the development of precision treatments and nutrition for patients with obesity, optimizing their benefit after BS.

show abstract

“…Bariatric surgery offers a more drastic and more lasting weight-lowering potential, while it may reverse prediabetes and T2DM in a significant proportion of patients [10]. However, bariatric surgery, while offering the most regarding obesity, it is also associated with severe adverse effects [12,13].…”

Section: Introductionmentioning

confidence: 99%

SGLT-2 inhibitors in obesity and its associated cardiometabolic disorders: where do we stand?

Tsilingiris¹,

Kounatidis²,

Lempesis³

et al. 2022

Polish Archives of Internal Medicine

Self Cite

View full text Add to dashboard Cite

As the tide of obesity and its complications is on the rise, there is an urgent need for new drugs with weight-lowering and beneficial metabolic properties. Obesity-related disorders, such as metabolic syndrome, prediabetes, type 2 diabetes mellitus (T2DM), cardiovascular disease and non-alcoholic fatty liver disease (NAFLD) make this need more than mandatory. Sodium-Glucose Co-Transporter-2 (SGLT-2) inhibitors (empagliflozin, canagliflozin, dapagliflozin, and ertugliflozin) are the latest class of agents to receive approval for the treatment of T2DM. Not long after their marketing, a wide spectrum of target organ-protective and overall beneficial health effects associated with their use began to unveil. An increasing bulk of evidence points towards that these actions are to a great degree independent of glucose lowering, which has led to the broadening of the indications of SGLT-12 inhibitors outside the frame of antihyperglycemic therapy. Additionally, their unique mode of action including an increased renal glucose excretion and hence, net energy loss could render SGLT-2 inhibitors attractive candidates for the treatment of obesity. Very few reviews in the literature have appraised holistically the therapeutic potential of SGLT-2 inhibitors in obesity and its associated complications. Herein, we synopsize the currently available evidence regarding the effects of drugs of this class on body adiposity, together with considerations which accompany their potential use with the aim of weight loss. Furthermore, we attempt an overview of their actions and future perspectives of their use with respect to a range of obesity-related disorders, which include cardiovascular, renal, as well as NAFLD, malignancy, and ovarian dysfunction.

show abstract

Nutritional Deficiencies Before and After Bariatric Surgery: Prevention and Treatment

Cited by 27 publications

References 25 publications

Assessment of the Clinical Condition and Way of Patients’ Nutrition before and after Laparoscopic Sleeve Gastrectomy

Assessment of the Clinical Condition and Way of Patients’ Nutrition before and after Laparoscopic Sleeve Gastrectomy

Precision nutrition in the context of bariatric surgery

SGLT-2 inhibitors in obesity and its associated cardiometabolic disorders: where do we stand?

Contact Info

Product

Resources

About